Skip to main content
. 2008 Dec 22;53(3):1067–1073. doi: 10.1128/AAC.00860-08

TABLE 1.

Characteristics of the HIV-infected pregnant women (n = 38) enrolled in the pharmacokinetic study of the TEmAA ANRS 12109 trial, step 1

Covariate Median (min-max)
Maternal BW at delivery (kg) 58.3 (46.5-88.1)
Gestational age (wk) 39 (33-42)
Delivery (vaginal, caesarian section)
    (no. of patients) 24, 14
Maternal creatinine clearance at enrollment
    (μmol/liter) 42.2 (26-88)
Neonatal BW at birth (kg) 2.7 (2.3-3.6)
Neonatal ht at birth (cm) 48.5 (46-53)
Body surface area at birth (m2) 0.20 (0.18-0.23)